Welcome to our dedicated page for Splash Beverage Group SEC filings (Ticker: SBEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Splash Beverage Group, Inc. (NYSE American: SBEV) files a range of reports and disclosure documents with the U.S. Securities and Exchange Commission that provide detailed information about its beverage-focused business, capital structure, and governance. As a smaller reporting company and emerging growth company, Splash Beverage Group submits registration statements, current reports, and periodic filings that together outline its strategy of managing brands across consumer beverage growth segments and its reliance on external capital to fund operations.
Among the key documents are S-1 registration statements, which describe the company’s business model, including its focus on incubating and acquiring beverage brands, its e-commerce platform Qplash, alcoholic beverage operations involving Chispo tequila, acquisition of water extraction rights in Costa Rica (the Water Assets), and a joint venture for adult THC and CBD beverage products. These filings also detail the company’s lack of revenue since March 2025, its financing needs for specific projects, and its consideration of strategic alternatives such as potential acquisitions.
Current reports on Form 8-K disclose material events such as private placements of secured promissory notes, issuances of convertible preferred stock and warrants, entry into equity line of credit agreements, adoption of the 2025 Equity Incentive Plan, amendments to bylaws, and changes in executive officers. Other filings, such as Form NT 10-Q, explain delays in periodic reports and provide preliminary information about expected results of operations, including anticipated net losses and operating expenses.
On Stock Titan’s SBEV filings page, users can access these SEC documents in one place, with real-time updates as new filings appear on EDGAR. AI-powered summaries help explain complex items such as S-1 registration statements, 8-K disclosures, and equity incentive plan terms in more accessible language. Investors can also review filings related to unregistered sales of equity securities, note financings, and equity line arrangements to better understand dilution, financing costs, and the company’s capital-raising approach.
For those interested in governance and shareholder matters, filings covering annual meetings, voting results, and board or officer changes provide additional context. Together, these SEC filings form a detailed record of Splash Beverage Group’s regulatory history, financing activities, and strategic direction within the consumer beverage industry.
Splash Beverage Group appointed Francis Knuettel II to its Board of Directors, effective April 27, 2026. He will also serve on the Audit Committee, Compensation Committee, and the Corporate Governance and Nominating Committee.
Knuettel brings experience as a senior executive at early-stage public companies. He previously served as Chief Financial Officer of Pelthos Therapeutics Inc. from June 2022 to April 2026, Chief Executive Officer of Pelthos from July 2023 to July 2025, and as a director of Pelthos from August 2024 to July 2025. He also led Unrivaled Brands as Chief Executive Officer and director from December 2020 to March 2022.
The company states there are no arrangements or understandings with other parties regarding his appointment, no family relationships with existing directors or executive officers, and no related-party transactions requiring disclosure under Regulation S-K Item 404(a).
Splash Beverage Group, Inc. amended settlement agreements with three prior investors, extending payment of remaining settlement amounts of $535,595 to June 1, 2026, with 12% interest and investor attorneys’ fees, and committing to additional installments totaling $100,000 by May 15, 2026.
Board members Justin Yorke and Robert Nistico resigned, and Nistico entered a six‑month consulting agreement at $5,000 per month plus a stock option for 250,000 shares subject to vesting tied in part to a potential Medterra CBD, LLC acquisition. The company also received a demand letter from Decathlon Alpha IV, L.P. seeking immediate payment of obligations under a revenue loan agreement totaling $2,833,395.98 as of March 31, 2026, secured by the assets of Splash Beverage and its subsidiaries, which the company disputes.
Splash Beverage Group, Inc. filed an 8-K describing a change to its capital structure. On April 17, 2026, the company filed a Certificate of Withdrawal with the Nevada Secretary of State, terminating the designation of its Series A Preferred Stock, par value $0.001 per share.
At the time of this filing, there were no Series A preferred shares issued or outstanding. The withdrawal became effective upon filing and removed from the Articles of Incorporation all provisions contained in the prior Certificate of Designation for the Series A series. The full text is included as Exhibit 3.1.
Splash Beverage Group, Inc. reports its annual results and describes severe liquidity challenges for the year ended December 31, 2025. The company generated net revenues of only $442,732 in 2025 and recorded a net loss from continuing operations of approximately $25.2 million, including $14.2 million of non-cash items.
Auditors raised substantial doubt about Splash’s ability to continue as a going concern due to recurring losses, working capital and stockholders’ equity deficits, and dependence on new financing. After rescinding a Costa Rica water-assets deal and canceling related Series C preferred stock, Splash reported a stockholders’ deficit of $15,300,828 at December 31, 2025, below the NYSE American’s $6 million minimum equity requirement, creating delisting risk.
The company is pursuing a transformative acquisition of Medterra CBD, LLC under a non-binding letter of intent valuing Medterra at $37.6 million, contemplating approximately 54.4 million shares of common and preferred stock, repayment of about $10.4 million of Medterra debt, and additional cash for Medterra investors’ taxes. Splash estimates needing roughly $10 million to close and further capital of about $25 million to expand Medterra’s operations. It also plans to revive beverage revenues via its Chispo Tequila brand, including a house-tequila placement with Senor Frog’s, but estimates at least $2 million in working capital plus $500,000 to build Chispo and about $3 million for broader operating needs.
Splash Beverage Group, Inc. notified the SEC it cannot timely file its Form 10-K for the fiscal year ended December 31, 2025 due to limited personnel and financial resources and an ongoing audit by its independent registered public accounting firm. The company expects to file the Form 10-K on or prior to the 15th calendar day following the prescribed due date, as permitted under Rule 12b-25.
The company states it expects 2025 revenue of approximately $0.4 million versus $4.2 million in 2024, a decrease of about $3.8 million attributed to lack of operating capital that hindered sales. The expected figures are subject to revision based on the completion of the audit.
Splash Beverage Group, Inc. entered into a non-binding letter of intent with Medterra CBD, LLC for a potential merger. The proposed terms value Medterra at $37.6 million, with consideration structured as approximately 75,200,000 shares of Splash common and new Series X and Series X-1 preferred stock.
The structure includes issuing common shares at closing equal to up to 19.99% of Splash’s then-outstanding common stock, with the balance in Series X and X-1 preferred, convertible at $0.50 per share and carrying a 110% original issue discount. Conversion and voting on these preferred shares are blocked until shareholder approval of the change of control. Splash must raise capital to repay about $10.4 million of Medterra debt, and up to $5 million of preferred may be redeemed from future offering proceeds. The LOI also requires Medterra to deliver at least $4 million in working capital at closing and provides for liquidated damages of $250,000 if shareholder approval is not sought within specified timelines.
Splash Beverage Group entered into a non-binding letter of intent for a proposed business combination with Medterra CBD, LLC, a cannabinoid wellness company that generated over $52 million in revenue and was profitable in fiscal 2025.
The deal would reposition Splash as a public cannabinoid wellness platform focused on regulated consumer health and a house-of-brands strategy, while exploring potential participation in a federal CBD pilot initiative under evaluation by CMS. The transaction remains subject to definitive agreements, shareholder and third‑party approvals, capital raising, lender consents and NYSE American change‑of‑control approval.
SPLASH BEVERAGE GROUP, INC. filed an initial ownership report for director Brady James Cobb on Form 3. This filing establishes his status as an insider and discloses that there are currently no reported share purchases, sales, acquisitions, or dispositions associated with this filing.
Splash Beverage Group expanded its Board of Directors to five members and appointed Brady Cobb as a new director, effective February 2, 2026. The company states there are no related-party arrangements, family relationships, or disclosable transactions connected to his appointment.
In an accompanying press release, Splash links Cobb’s addition to its “Splash 2.0” strategic reset, which emphasizes refreshed governance, disciplined execution, and expansion into high‑growth consumer categories, including federally compliant CBD and hemp. The company highlights Cobb’s regulatory, policy, and capital markets experience in cannabis and hemp as important to pursuing these opportunities under evolving U.S. rules.
Splash Beverage Group, Inc. reported recent unregistered equity transactions. The company sold 145,029 shares of common stock for gross proceeds of $98,170 under a previously disclosed equity line of credit agreement dated September 19, 2025. It also issued 360,648 shares of common stock upon converting a total of $200,000 of convertible promissory notes on October 27, 2025, November 25, 2025, and December 11, 2025. These share sales and conversions were conducted under Securities Act exemptions, including Section 4(a)(2), Rule 506(b), and Section 3(a)(9).